VOCI, SILVIA

VOCI, SILVIA  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.052 secondi).
Titolo Data di pubblicazione Autore(i) File
Antitumor features of vegetal protein-based nanotherapeutics 1-gen-2020 Voci, S.; Gagliardi, A.; Fresta, M.; Cosco, D.
Application of Biocompatible Drug Delivery Nanosystems for the Treatment of Naturally Occurring Cancer in Dogs 1-gen-2022 Ambrosio, N.; Voci, S.; Gagliardi, A.; Palma, E.; Fresta, M.; Cosco, D.
Ascorbic acid-loaded gliadin nanoparticles as a novel nutraceutical formulation 1-gen-2022 Voci, S.; Gagliardi, A.; Fresta, M.; Cosco, D.
Brij-stabilized zein nanoparticles as potential drug carriers 1-gen-2021 Gagliardi, A.; Voci, S.; Salvatici, M. C.; Fresta, M.; Cosco, D.
Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles 1-gen-2023 Gagliardi, Agnese; Voci, Silvia; Ambrosio, Nicola; Fresta, Massimo; Duranti, Andrea; Cosco, Donato
Development of polyoxyethylene (2) oleyl ether-gliadin nanoparticles: Characterization and in vitro cytotoxicity 1-gen-2021 Voci, S.; Gagliardi, A.; Salvatici, M. C.; Fresta, M.; Cosco, D.
Easy preparation, characterization and cytotoxic investigation of 5-Fluorouracil-loaded zein/sericin nanoblends 1-gen-2022 Gagliardi, A.; Ambrosio, N.; Voci, S.; Salvatici, M. C.; Fresta, M.; Cosco, D.
Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity 1-gen-2023 Voci, S.; Gagliardi, A.; Ambrosio, N.; Salvatici, M. C.; Fresta, M.; Cosco, D.
Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations 1-gen-2023 Voci, S.; Pangua, C.; Martinez-Oharriz, M. C.; Aranaz, P.; Collantes, M.; Irache, J. M.; Cosco, D.
Gliadins as versatile biomaterials for drug delivery applications 1-gen-2021 Voci, S.; Fresta, M.; Cosco, D.
Influence of the Dispersion Medium and Cryoprotectants on the Physico-Chemical Features of Gliadin-and Zein-Based Nanoparticles 1-gen-2022 Voci, S.; Gagliardi, A.; Salvatici, M. C.; Fresta, M.; Cosco, D.
Influence of the Physico-Chemical Properties of Model Compounds on the Mean Sizes and Retention Rate of Gliadin Nanoparticles 1-gen-2021 Voci, Silvia; Fresta, Massimo; Cosco, Donato
Influence of Various Model Compounds on the Rheological Properties of Zein-Based Gels 1-gen-2020 Gagliardi, A.; Voci, S.; Paolino, D.; Fresta, M.; Cosco, D.
Phospholipid/zein hybrid nanoparticles as promising carriers for the protection and delivery of all-trans retinoic acid 1-gen-2021 Gagliardi, A.; Voci, S.; Giuliano, E.; Salvatici, M. C.; Celano, M.; Fresta, M.; Cosco, D.
Recent advances of taxol-loaded biocompatible nanocarriers embedded in natural polymer-based hydrogels 1-gen-2021 Voci, S.; Gagliardi, A.; Molinaro, R.; Fresta, M.; Cosco, D.
SCLAREIN (SCLAREol contained in zeIN) nanoparticles: Development and characterization of an innovative natural nanoformulation 1-gen-2021 Gagliardi, A.; Voci, S.; Bonacci, S.; Iriti, G.; Procopio, A.; Fresta, M.; Cosco, D.
Strategies of stabilization of zein nanoparticles containing doxorubicin hydrochloride 1-gen-2023 Ambrosio, N.; Gagliardi, A.; Voci, S.; Salvatici, M. C.; Fresta, M.; Cosco, D.